Skip to main content
Clinical Trials/ACTRN12613000581763
ACTRN12613000581763
Completed
Phase 4

The impact of exercise and exercise-related reductions in insulin pump basal delivery on circulating insulin levels in type 1 diabetes

St Vincent's Hospital Melbourne0 sites14 target enrollmentMay 23, 2013

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Type 1 diabetes
Sponsor
St Vincent's Hospital Melbourne
Enrollment
14
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 23, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
St Vincent's Hospital Melbourne

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of type 1 diabetes, managed with insulin pump therapy for minimum of 3 months, established insulin:carbohydrate ratio, established insulin sensitivity factor, established basal insulin delivery profile including overnight basal rate between 0\.50\-1\.40 units per hour (without significant overnight variation), able to tolerate moderate\-intensity exercise.

Exclusion Criteria

  • Symptoms of ischaemic heart disease or known cardiac condition precluding moderate\-intensity exercise, ischaemic changes on electrocardiogram, episode of diabetic ketoacidosis or severe hypoglycaemia (requiring third party assistance) within the last month, pregnant or planned pregnancy within study period, renal impairment (estimated glomerular filtration rate \<60 mL per minute), body mass index \<18 or \>32, adverse skin condition in the area of cannula or device placement, allergy to insulin aspart.

Outcomes

Primary Outcomes

Not specified

Similar Trials